Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRINCE I: Atazanavir Powder + Ritonavir in Pediatric HIV
NCT01099579Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Bristol Myers Squibb. Started Oct 2010; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01099579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099579.